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THERAPY AND PREVENTION
SURGERY
Comparative long-term effects of coronary artery
bypass graft surgery and percutaneous transluminal
coronary angioplasty on regional coronary flow
reserve
ERIC R. BATES, M.D., FRED M. AUERON, M.D., VICTOR LEGRAND, M.D., MICHAEL T. LEFREE, B.S.,
G. B. JOHN MANCINI, M.D., JOHN M. HODGSON, M.D., AND ROBERT A. VOGEL, M.D.
ABSTRACT To evaluate the relative long-term improvement in coronary artery hemodynamics after
revascularization by coronary artery bypass graft surgery (CABG) or percutaneous transluminal coro-
nary angioplasty (PTCA), regional coronary flow reserve (CFR) was measured, by digital computer
analysis of 35 mm cine film, in 50 men undergoing cardiac catheterization. CFR (mean ± SEM) in 12
atherosclerotic arteries before revascularization was 1.02 + 0.05. Mean CFR in 29 normal arteries of
men with normal coronary arteriograms was significantly higher (2.59 + 0.11) than that in 16
atherosclerotic arteries of patients revascularized by CABG (2.02 + 0. 17, p < .01) or in 14 atheroscle-
rotic arteries of those revascularized by PTCA (1.97 + 0.12, p < .01). No difference in CFR between
the CABG and PTCA groups was found and variables known to influence CFR were similar between
groups. Equivalent and significant long-term improvement in coronary artery hemodynamics is pro-
vided by CABG or PTCA. We postulate that the difference in CFR in the men with normal arteries and
those who underwent revascularization was related to the effects of the general atherosclerotic process,
which remain despite successful treatment by these techniques.
Circulation 72, No. 4, 833-839, 1985.
MYOCARDIAL REVASCULARIZATION can now
be accomplished by either coronary artery bypass graft
surgery (CABG) or percutaneous transluminal coro-
nary angioplasty (PTCA).`- Although symptomatic,
metabolic, hemodynamic, and functional improve-
ment has been demonstrated with each technique,5-'5
little data exist comparing the two. 6. 17 One difficulty
in undertaking comparative studies resides in the clini-
cal disparities in groups of patients undergoing these
procedures. While patients who undergo CABG are
more likely to have chronic symptoms, a history of
myocardial infarction, and multivessel disease, those
treated by PTCA characteristically have recent onset of
symptoms, normal ventricular function, and single-
vessel disease. More importantly, the lack of a gener-
ally available clinical test sensitive enough to evaluate
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subtle regional differences in coronary blood flow or
myocardial function due to either technique has inhib-
ited investigation.
The coronary reactive hyperemic response is an im-
portant, reproducible physiologic parameter. l' 1' It can
be measured by determining the ratio of maximal coro-
nary blood flow to resting flow. Increasingly signifi-
cant obstructive coronary artery disease progressively
exhausts this coronary flow reserve (CFR) by reducing
peak flow.20 2 Three techniques have recently been
developed that allow the measurement of regional CFR
in man. The first uses a pulsed Doppler coronary artery
catheter, which can measure proximal coronary flow
velocity in the catheterization laboratory.2-2 The second
uses a Doppler velocity probe, which can be applied
directly to selected epicardial coronary arteries at the
time of open heart surgery to measure the reactive
hyperemic response to transient arterial occlusion.25
The third is a digital radiographic technique performed
during routihe cardiac catheterization that measures
the myocardial reactive hyperemic response to intra-
coronary injection of contrast medium.24 25
The present study, in which we used the third tech-
833 at UNIV MEDECINE LEIG 228272 on May 27, 2014http://circ.ahajournals.org/Downloaded from 
BATES et al.
nique, was designed to evaluate the relative improve-
ment in long-term regional CFR after myocardial re-
vascularization by CABG or PTCA.
Methods
Patient population. The patient population consisted of 50
men undergoing coronary arteriography. These patients were
divided into four groups for analysis. Group I was composed of
10 patients with symptomatic coronary artery disease (a total of
12 diseased arteries) who subsequently underwent revasculari-
zation by CABG or PTCA. Eleven patients with 16 arteries
previously treated by CABG formed group II, and 13 patients
with 14 arteries previously treated by PTCA formed group III;
these patients were studied to evaluate postrevascularization
vessel patency. In group Il patients all grafts were patent and
nonstenotic, and in those in group III there was a residual
translesional pressure gradient of 20 mm Hg or less at the time
of angioplasty and no angiographic evidence of restenosis at
follow-up. Twenty-nine arteries in 16 patients with atypical
chest pain and normal coronary arteriograms formed group IV
and served as the normal control group. Patients were excluded
if they had valvular heart disease, electrocardiographic evi-
dence of left ventricular hypertrophy, more than mild hypokine-
sis documented on the contrast ventriculogram, or angiographi-
cally visible coronary collateral vessels. Data from 15% of
arterial distributions were excluded from analysis because of
use of an inadequate contrast injection technique, motion arti-
fact, poor visualization of the perfusion bed, or failure of the
angiographer to acquire arteriographic data suitable for digital
processing.
Prescribed medication regimens were not followed the morn-
ing of the cardiac catheterization. Patients were premedicated
with 10 mg diazepam and 50 mg diphenhydramine. This study
was approved by the institutional committees on human re-
search and informed consent was obtained from each patient.
Arteriographic technique. To obtain images for digital
processing, the following arteriographic technique was used.
Standard left ventriculography and multiple-view selective
coronary arteriography were performed by the Judkins tech-
nique. Arteriography for subsequent functional image digital
processing was obtained in the left anterior oblique projection
on 35 mm cine film. Fixed parameter (kV, mA, and pulse
width) cineradiography at 30 frames/sec was used. Patients
were required to cease respiration and remain motionless during
filming. Vein grafts and coronary arteries were opacified by a
fixed dose of 5 to 8 ml of sodium meglumine diatrizoate (Reno-
grafin-76) injected by an electrocardiographically triggered
power injector gated to the R wave of the electrocardiogram.
Reflux of contrast medium into the aorta was considered proof
that a maximal bolus of contrast was delivered to the artery and
that the catheter was not impeding coronary blood flow. Base-
line studies were performed at least 3 min after the previous
injection of contrast. Studies under hyperemic conditions were
performed 10 sec after intracoronary injection of an identical
dose of contrast medium. Cineradiography was initiated at least
one full cardiac cycle before injection of contrast. A density step
wedge was imaged and checked densitometrically after film
processing to ensure that the film gray scale was kept constant
on a day-to-day basis.
Digital processing of the functional image. Digital image
processing was performed by a technique similar to that pre-
viously described.2 27 Three general operations were required:
digitization, mask-mode substraction, and functional image
generation. Arteriograms were displayed on a cine film projec-
tor (Vanguard Corporation, XR-35) equipped with a primary
beam splitter coupled to a fixed-gain video camera and a video
analog-to-digital converter. Five to seven end-diastolic frames
from consecutive cardiac cycles were chosen, with use of the
criterion of closest duplication of arterial position, beginning
with the end-diastolic frame just before injection of contrast
medium. These frames were digitized into 512 x 512 x 8-bit
matrixes. Video-amplified gain and projector light levels were
adjusted to provide a linear correspondence between contrast
x-ray absorption and digital scale. The digital images were
stored in the disk memory of a digital radiographic computer
(DPS-4100C. ADAC Labs, Edenvale, CA) for subsequent
processing.
Image enhancement was performed by standard mask-mode
subtraction with use of the end-diastolic frame before injection
of contrast as the mask. A single contrast intensity and appear-
ance time-modulated functional image was then generated from
each set of enhanced frames (figure 1).25 The intensity value of
each pixel corresponded to the maximum contrast density
reached during each acquisition, while the appearance time of
contrast in the pixel was color modulated, with a different color
assigned to each postinjection cardiac cycle (red for the first
cycle, yellow for the second, etc.). Only pixels with an intensity
above a preset threshold appeared on the final functional image.
This threshold was manually set at a level that excluded most of
the background noise intensity. Acquisition and processing
were identical for each pair of basal and hyperemic images so
that each set was technically comparable.
Analysis of functional images. Mean myocardial contrast
density and appearance were determined by a computer pro-
gram that averaged pixel values in a region of interest defined by
the operator in the basal images and in the same area of the
hyperemic images (figure 1). Large epicardial coronary arteries
and areas that overlapped with the aortic root, diaphragm, or
coronary sinus were excluded from analysis. Since contrast
density is directly related to the volume of distribution in the
myocardium and flow is inversely related to myocardial contrast
appearance time, digital estimation of coronary blood flow was
calculated as
Q Xc volume/time x CD/AT
where Q = mean regional cornary flow; CD = mean maximal
contrast density; and AT = mean contrast appearance time.
CFR, the ratio of hyperemic (H) flow to basal (B) flow, correct-
ed for heart rate (HR), was calculated as
CFR= QH/QB = CDH/CDB X ATB/ATH x HRH/HRB
Studies in dogs have demonstrated an excellent correlation be-
tween CFR measured by electromagnetic flow probe and the
ratio CD/AT measured by digital subtraction angiography (r =
.92). The digital measurements were accurate (regression slope
= .90), reproducible (+- 13%), and had low interobserver (r
.99) and intraobserver (r = .98) variability.25
Data analysis. Data are expressed as mean + SEM. Statisti-
cal comparisons between groups were obtained with the two-
tailed, unpaired t test. Significant differences were assumed
when confidence limits exceeded 95% (p < .05).
Results
Clinical characteristics. The clinical characteristics of
the patients groups are listed in table 1. Nine of 11
patients in group II (CABG) had triple-vessel disease,
while nine of 13 patients in group III (PTCA) had
single-vessel disease. Forty-two of the 48 diseased
arteries in group II and III patients were successfully
revascularized. Two patients each in groups II and III
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FIGURE 1. Conit -ast miiediuILIm appearance pictLrCes fa na olt mal rigeht caot00dB atter in thle ii ititeitol- obiiuLeC projectionls at
baselinle (/efit and Linidet l\peIci-ciz tJi conditions. CFR was calculated to be 2.49 in the ecionl at interest.
still had exertional chest pain; the others were pain
free. The hemiioglobin averaged 14.9 + 0.7 gldl in
group II and 15.0 + 0.3 g/dl in group III and the
interval between revascularization and catheterization
in these two groups was 15.4 ± 2.0 and 32.6 ± 4.2
weeks, respectively.
Cardiac catheteri7zationi. Data obtained at cardiac
catheterization for the four patient groups are listed in
table 2. There were no signiificant dilferences in heart
rate, mean aortic pressure, or pressure-rate product
between groups. Althougrh group Ill patients had a
significantly lower left ventricular ejection fraction
than the men with normal arteries (group IV) (p <
.01), the value was not statistically different from that
in group 11, and was well within normal physiologic
limits. No difference in left ventricular end-diastolic
pressures existed. Percent luminal stenosis of arteries
was 80 + 4% in group I and 17 ± 3% in group Ill.
CFR. Individual values for CFR for each group are
plotted in figure 2. CER in five patients who subse-
Vol. 72, No. 4. OctobeI 1985
quently underwent CABG and in five patients who
subsequently underwent PTCA are grouped together in
group I because they were equivalent (l. 1u ± 0.05 vs
0.95 + 0.06). Mean values for CFR for grcoups 1, 11,
Ill, and IV were 1.02 ± 0.05, 2.02 + 0.17, 1.97 +
0. 12, and 2.59 ± 0.1 1, respectively. While CFR in
patients with atheroscleriotic arteries revascularized by
CABG or PTCA was significantly higher than in those
with arteries not revascularized (p < .0001), it was
significantly lower than CFR in men with normal arter-
ies (p < .(01). No difference in CFR in groups II and III
was found.
Discussion
Autoregulatory changes maintain basal coronary
blood flow in arteries with flow-limiting stenoses by
decreasing distal coronary resistance, but this limits
potential further increases in flow. In arteries with
high-grade stenoses suitable for revascularization by
CABG or PTCA, CFR is exhausted. An improvement
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TABLE 1
Characteristics of the 50 study patients
Group I Group II Group III Group IV
(n = 10) (n = 11) (n = 13) (n = 16)
Age (yr)A 56+3 57+2 55+3 48+2
No. of diseased vessels 19 31 17 0
No. of vessels revascularized 18 27 15 0
No. of vessels studied 12 16 14 29
LAD 7 5 6 9
Diagonal branch 0 3 0 0
Left circumflex 2 6 2 8
RCA 3 2 6 12
Medications before testing
Nitrates 10 3 3 10
,f-blockers 2 9 0 11
Ca+ +-blockers 6 2 9 3
LAD = left anterior descending artery; RCA
AMean ± SEM.
right coronary artery.
in individual arterial CFR several months after CABG
and immediately after PTCA, as measured by coronary
radiography, has been demonstrated previously.26 27
We have since modified our image analysis algorithm
and use contrast density information to reflect regional
vascular volume and the CD/AT ratio to more accu-
rately estimate coronary blood flow.25 While the CFR
values found for vessels without severe obstruction are
higher when CD/AT ratios than when AT ratios are
used,2 27 findings with both methods indicate that CFR
is absent in vessels with high-grade stenoses suitable
for revascularization. In this report, the long-term ef-
fects of revascularization as determined by these two
techniques were compared with this refined image al-
gorithm. Equivalent and significant long-term im-
provements in regional CFR were found in arteries
revascularized by either CABG or PTCA. Additional-
ly, even though revascularization was quite successful
in each artery, normal CFR was not restored.
Clinical implications. CABG has been the most popu-
lar means of restoring regional myocardial blood flow
to perfusion beds distal to coronary stenoses for 15
years. More recently, PTCA has emerged as an alter-
native revascularization treatment for single-vessel ob-
structive coronary artery disease. It has clearly been
demonstrated that successful revascularization by
CABG or PTCA produces symptomatic, metabolic,
hemodynamic, and functional improvement.'-" The
current investigation is the first to suggest that equiv-
alent improvement in individual coronary artery hemo-
dynamics is achieved by the two techniques and further
justifies the use of revascularization by CABG or
PTCA in properly selected patients.
Theoretical implications. The failure of successful re-
vascularization to restore normal CFR to atherosclerot-
ic coronary arteries is probably the most interesting
finding of this study and one for which an explanation
is not readily apparent. The patients in each group had
equivalent basal oxygen demands, as estimated by
pressure-rate product, and normal global left ventricu-
lar function. Patients with severe regional wall motion
abnormalities, collateral blood flow, or left ventricular
hypertrophy were excluded because these factors can
have an effect on CFR independent of that of coronary
TABLE 2
Cardiac catheterization data
Group I Group II Group III Group IV
(n = 10) (n = 11) (n = 13) (n = 16)
Heart rate (beats/min) 75+2 75+3 74+3 71 3
Mean aortic pressure (mm Hg) 92 3 95 4 97 3 93 3
Pressure-rate product ( x 10 ') 99 + 4 96 + 5 98 ± 5 90 + 6
Left ventricular ejection fraction (%) 65 ± 4 67 + 3 59 + 3A 73 ± 3
Left ventricular end-diastolic pressure (mm Hg) 13 ± 2 10 + 2 14 ± 2 13 + 1
Data expressed as mean + SEM.
Ap < .01, as compared with the control group (group IV).
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FIGURE 2. Long-term CFR values for the patient groups as determined
by digital coronary radiography. CAD = coronary artery disease.
stenoses.28-31 By using contrast medium as a direct
vasodilator stimulus, rather than depending on the is-
chemic stimulation of vessel occlusion often used in
the operating room, we avoided measurement of any
influence dual blood supply may have had on determi-
nations of graft CFR. Also, the arteries subjected to
PTCA had very mild residual luminal stenoses and
would thus not be expected to be associated with limi-
tations of peak coronary blood flow.20 21 In the early
postrevascularization period patients were receiving
antianginal medications prescribed by their referring
physicians for prophylactic reasons, not because of
persistent ischemia; none received antianginal medica-
tions on the day of the catheterization.
It is unlikely that use of a saphenous vein graft as the
proximal conduit for coronary blood flow influences
coronary artery hemodynamics. No change in timing
of the resting pulse wave, pressure contour, or distal
blood flow was found by Kakos et al.32 in bypassed
normal canine coronary arteries. Others have shown
graft CFR to be normal in the canine model.` Like-
wise, Brandt et al.34 have demonstrated restoration of
normal CFR by CABG in a nonatherosclerotic human
right coronary artery originating from the left sinus of
Valsalva.
It is postulated that the difference in CFR in men
with normal arteries and those who underwent revas-
cularization is related to the atherosclerotic disease
process. First, although obstructive coronary artery
disease, as defined by the coronary arteriogram, is
Vol. 72, No. 4, October 1985
often detected as discrete proximal luminal stenoses
treatable by CABG or PTCA, anatomic descriptions
have repeatedly demonstrated the diffuse nature of
atherosclerotic plaque in diseased epicardial coronary
arteries.5"- Secondly, local vasomotor reactivity may
not be normal in atherosclerotic arteries. Neovascular-
ization in the region of atherosclerotic plaque has been
visualized by cinematography after silicone polymer
injections into the arteries of isolated human hearts.38
These transmural vascular networks potentially pro-
vide higher concentrations of vasoconstrictor sub-
stances and the proliferation of autonomic nerve termi-
nals known to accompany neovascularization may
enhance local catecholamine levels.38 Also, endotheli-
al damage due to mechanical injury or atherogenesis
has been shown to inhibit arterial smooth muscle relax-
ation.39 40 Finally, vascular reactivity at the arteriolar
level may be affected by the atherosclerotic disease
process through intimal thickening and fibrosis,41 al-
tered a-adrenergic tone,42 or chronic microemboliza-
tion of platelet aggregates.43
The effect of experimental atherosclerosis on CFR
has been studied in the cynomolgus monkey.44 After an
atherogenic diet was given to induce lesions producing
an average of 60% luminal stenosis, a normal diet was
given for a regression period of 18 months. While the
degree of stenosis was reduced to 25%, intimal fibrosis
was increased and CFR was only partially restored.
The authors concluded that intimal fibrosis substantial-
ly limited arterial hemodynamic improvement.
Study limitations. The limitations of the digital radio-
graphic technique we used have been previously sum-
marized and include those related to specific hardware
requirements, motion artifact, use of contrast medium
as the hyperemic stimulus, and the mathematic as-
sumptions necessary for calculation of blood
flow.2-27 45 Despite these difficulties, a good correla-
tion between electromagnetic flowmeter and digital
radiographic determinations of relative regional CFR
has been demonstrated.29 Also of concern is the fact
that about a quarter of the normal CFR values were less
than 2. We have recently shown that patients with
chest pain, normal coronary arteriograms, and low
regional CFR frequently have associated regional ab-
normalities on radionuclide exercise tests.46 These pa-
tients probably have ischemic heart disease without
epicardial coronary stenoses.47 48 Since this normal
group was defined only by the arteriogram, without
radionuclide exercise test data, it is likely that the
difference in CFR in the group with normal arteries
and the group undergoing revascularization is larger
than stated.49 The wide range of CFR values found in
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each patient group probably reflects the multiplicity of
factors that can influence arterial CFR.49 5
In summary, revascularization by CABG or PTCA
restores equivalent CFR to individual coronary arter-
ies. Although normal CFR is not achieved, this im-
provement in coronary arterial hemodynamics is suffi-
cient to reverse clinically detectable myocardial
ischemia. The difference in CFR in normal and revas-
cularized arteries requires further evaluation. Confir-
mation that physiologic perturbations accompany the
previously documented anatomic changes caused by
the presence of coronary atherosclerosis, despite suc-
cessful revascularization of angiographically visible
proximal stenoses, would be of importance in under-
standing the pathophysiology of obstructive coronary
disease.
We are indebted to Mr. Glenn Beauman for technical assis-
tance and to Ms. Diane Bauer for assistance in preparing the
manuscript.
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